Adam D. Levy, CFO: Acrivon Therapeutics ACRV Buy · Filed 01/16

Trade details

Type: Insider buy
Amount: $15,014.4
Shares · price: 8,832 sh · $1.70 a share
Held after: 20,983 sh
Stock: Acrivon Therapeutics ACRV
Person: Adam D. LevyCFO
Trade date: 26/01/14
Filed: 26/01/16
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +72.7%

Acrivon Therapeutics trades, last 26 weeks

What else happened in Acrivon Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/15~02/13

Adam D. Levy's recent trades

No other trades yet.